Browse News
Filter News
Found 47,750 articles
-
Novavax released its second quarter financial results, showing a dramatic adjustment in its sales outlook, while BioNTech prepares to launch two variant-adopted bivalent shots.
-
Five years after joining Johnson & Johnson as head of research and development, Mathai Mammen is leaving abruptly to seek other opportunities outside the company.
-
Is the biopharma industry expanding or contracting? The simple answer is both. A report noted that more than 60 companies announced layoffs in the first half of 2022. Despite that, some companies are thriving.
-
Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
8/9/2022
Veru Inc. today announced that the Phase 3 COVID-19 study results of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
-
Blue Water Vaccines Announces $10 Million Private Placement Priced At-the-Market under Nasdaq Rules
8/9/2022
Blue Water Vaccines Inc. today announced that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase of 3,683,280 shares of common stock (or common stock equivalents in lieu thereof) in a private placement priced at-the-market under Nasdaq rules.
-
BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS
8/9/2022
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second-quarter 2022 financial results.
-
SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®
8/9/2022
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of procurement options under its 75A50118C00019 (19C) contract with the U.S. Department of Health and Human Services for the delivery to the U.S. government of intravenous (IV) formulation of TPOXX treatment courses valued at approximately $26 million.
-
NanoViricides Provides Additional Details on Its Rapid Monkeypox Drug Strategy
8/9/2022
NanoViricides, Inc. provides further details on its rapid drug development strategy for Monkeypox virus.
-
Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
8/9/2022
Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee will hold a meeting on September 22, 2022, to review data supporting the biologics license application (BLA) for RBX2660, a microbiota-based live biotherapeutic studied for its potential to reduce recurrent C. difficile infection (CDI) after antibiotic treatment.
-
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
8/9/2022
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2022 financial results on Friday, August 12, prior to the market open.
-
Medical Refrigerators Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2031
8/9/2022
Wilmington, Delaware, United States, Transparency Market Research Inc. – The refrigeration technology has come a long way to meet the requirements in the medical and healthcare industry.
-
High susceptibility of animal-borne disease transmission to humans has pushed the animal genetics market to surpass ~ US$ 8 Billion by 2026
8/9/2022
Fact.MR – A Market Research and Competitive Intelligence Provider: The global animal genetics market is expected to witness a CAGR of x% to reach ~US $ 8 Billion by the year 2026.
-
Atrial Flutter Treatment Market Demand by 2030: Increase in Number of People with Different Prevalent Conditions
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Atrial Flutter Treatment Market – Forecast to 2030,’ thoroughly examines the Atrial Flutter Treatment industry to provide essential data & information for the targeted readers.
-
Castration-Resistant Prostate Cancer Market Growth by 2030: Increased Burden of Prostate Cancer
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Castration-Resistant Prostate Cancer Market – Forecast to 2030,’ thoroughly examines the Castration-Resistant Prostate Cancer industry to provide essential data & information for the targeted readers.
-
Diabetes Insipidus Market Growth by 2030: Rise in Prevalence of Diabetes Insipidus and use of Anti-Diuretic Drugs Globally
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Diabetes Insipidus Market – Forecast to 2030,’ thoroughly examines the Diabetes Insipidus industry to provide essential data & information for the targeted readers.
-
Dysthymia Market Demand by 2030: Rise in Prevalence of Dysthymia, Increased Expenditure in R&D, and Increase in Mental Disorders
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Dysthymia Market – Forecast to 2030,’ thoroughly examines the Dysthymia industry to provide essential data & information for the targeted readers.
-
Emphysema Market Growth by 2030: Increase in Prevalence of Respiratory Diseases such as Chronic Bronchitis
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Emphysema Market – Forecast to 2030,’ thoroughly examines the Emphysema industry to provide essential data & information for the targeted readers.
-
Fallopian Tube Cancer Market Demand by 2030: Rising Fallopian Tube Cancer Incidences Globally
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Fallopian Tube Cancer Market – Forecast to 2030,’ thoroughly examines the Fallopian Tube Cancer industry to provide essential data & information for the targeted readers.
-
Impetigo Market Growth by 2030: Increase in Percentage of Suffering from Low Immunity
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Impetigo Market – Forecast to 2030,’ thoroughly examines the Impetigo industry to provide essential data & information for the targeted readers.
-
Mild Dry Eyes Market Growth by 2030: Increasing use of Electronic Devices such as Mobile Phones and Laptops
8/9/2022
The latest market analysis report published by Reports and Data, titled ‘Global Mild Dry Eyes Market – Forecast to 2030,’ thoroughly examines the Mild Dry Eyes industry to provide essential data & information for the targeted readers.